In the correlation analysis, the blood‐derived biomolecules associated with CSF biomarkers differed between APOE ε4 carriers and non‐carriers among AD patients, suggesting distinct roles of APOE genotypes in AD pathology. Here, APOE is linked to Alzheimer disease.